drugset / Trial / NCT00270101
The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of epoetin alfa versus placebo in reducing the transfusion requirements in anemic patients with multiple myeloma, and to investigate the quality-of-life benefits associated with the use of epoetin alfa. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.
Timeline
- Start
- 1995-01
- Primary completion
- —
- Completion
- 1996-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 150 iu/kg | Subcutaneous |
| Subject | epoetin alfa | Protein / enzyme biologic | 300 iu/kg | Subcutaneous |